Metaplex (Early Bird) airdrop
Metaplex is a decentralized protocol on the Solana blockchain, trusted for creating, selling, and using digital assets due to its scalability and innovative features like "Proof of History." Metaplex offers tools, smart contracts, and more to simplify the process of creating and launching NFTs. The user-friendly Metaplex Creator Studio allows anyone to easily create, sell, and manage Solana NFTs without coding. The Metaplace, in collaboration with metaverse builders and Metaplex Foundation grant recipients, Chapter X, is a dynamic space. The Metaplex Token ($MPLX) is the governance and utility token for the Metaplex Protocol, which powers the Solana NFT ecosystem.
~$ 3,300,000 Prize Pool
Est. value
About Metaplex (Early Bird)
MPLX tokens are distributed to eligible international developers, creators, and artists based on previous wallet activity within the ecosystem. Sign-ups for this Airdrop are closed. Metaplex utilizes the Solana blockchain for its scalability and features such as "Proof of History." Metaplex offers tools, smart contracts, and resources to simplify the process of creating and launching NFTs. The Metaplex Creator Studio enables users to easily create, sell, and manage Solana NFTs without the need for coding knowledge. Metaplace is a dynamic space developed in collaboration with Metaplex Foundation grant recipients, Chapter X. MPLX serves as the governance and utility token for the Metaplex Protocol, supporting the Solana NFT ecosystem.
Step-by-step guide
Head to the Metaplex Airdrop page. Connect your Solana wallet to check your eligibility. Claim your free $MPLX tokens. Congrats!
Disclaimer: This content is for educational and informational purposes only and does not constitute financial advice. Conduct thorough research before making any deposit/investment decisions (DYOR).
What will be the value of Bitcoin and Ethereum in 2025?
Project links
Third-party websites found on the internet are publicly accessible and have no affiliation with Bitget. It's crucial to assess the risks associated with using third-party websites independently and proceed with caution.
Popular cryptocurrencies
A selection of the top 8 cryptocurrencies by market cap.
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Buy and sell crypto in seconds 1. Create your free Bitget account
2. Verify your account
3. Buy, deposit, or sell your crypto
Sign upBecome a trader now?
A welcome pack worth 6200 USDT for new users!
Sign up nowUnitedHealth (UNH) Q4 2025 Earnings Overview
\nUnitedHealth Group (NYSE:UNH) reported fourth-quarter 2025 revenue that matched Wall Street’s expectations, posting a 12.3% year-over-year increase to $113.2 billion. However, the company’s projected full-year revenue of $439 billion fell 3.7% short of what analysts had anticipated. Adjusted earnings per share for the quarter came in at $2.11, aligning with consensus forecasts.
\n\nShould You Consider Buying UNH?
\nCurious if UnitedHealth is a smart investment right now?
\n\nKey Q4 2025 Metrics for UnitedHealth
\n\n - Total Revenue: $113.2 billion (12.3% annual growth), just below the $113.6 billion analyst estimate
\n - Adjusted EPS: $2.11, matching analyst expectations
\n - Adjusted EBITDA: $4.25 billion, missing projections by 3.7% with a 3.8% margin
\n - 2026 Adjusted EPS Guidance: $17.75 at the midpoint, in line with forecasts
\n - Operating Margin: 0.3%, a sharp decline from 7.7% a year ago
\n - Customer Count: 53.69 million, down from 54.08 million in the previous quarter
\n - Market Cap: $256.1 billion
\n
\n\nAnalysis and Outlook
\nThe fourth quarter presented notable hurdles for UnitedHealth, with leadership highlighting increased medical costs and fierce competition in Medicare Advantage as major factors. CEO Stephen Hemsley described this period as one of intense evaluation, stressing the importance of focusing on the company’s core strengths and realigning operations. The leadership team has initiated restructuring, asset sales, and a renewed commitment to operational discipline to lay the groundwork for future growth. Tim Noel, CEO of UnitedHealthcare, pointed out that aggressive plan shopping and ongoing funding reductions resulted in higher-than-expected losses in Medicare Advantage membership, while margin improvement efforts required tough choices on pricing and product offerings.
\nLooking ahead, UnitedHealth’s guidance reflects continued challenges from Medicare and Medicaid funding cuts and persistent high medical costs. The company’s strategy is centered on restoring margins, investing in operational improvements, and harnessing artificial intelligence to boost efficiency. Hemsley noted that meaningful progress in UnitedHealthcare is expected in 2026, while Optum’s margin growth will require further operational changes. Plans include repricing insurance products, optimizing market participation, and advancing technology initiatives. Patrick Conway, CEO of Optum, emphasized that a renewed focus on integrated, value-based care and network optimization should gradually improve performance, especially in the latter half of the year.
\n\nManagement Insights
\nLeadership attributed the quarter’s results to higher utilization in Medicare Advantage, competitive enrollment pressures, and restructuring across business units. Priorities included strategic repricing and streamlining operations to support margin recovery and future stability.
\n\n - Medicare Advantage Membership Decline: UnitedHealthcare saw greater-than-expected losses in Medicare Advantage enrollment due to ongoing funding cuts and stiff competition. Management prioritized margin improvement over membership growth, aiming for a 50 basis point margin increase in this segment.
\n - Medicaid and Commercial Challenges: State-level Medicaid funding shortfalls continue to pressure the business, leading to expected membership declines. In commercial lines, repricing in response to rising medical costs also led to planned reductions in membership, but these actions are intended to stabilize margins by 2026.
\n - Optum Restructuring: Optum underwent significant changes to better align with its value-based care strategy, including narrowing its provider network by nearly 20% and simplifying risk contracts to improve consistency and restore margin targets.
\n - AI and Automation: UnitedHealth is leveraging artificial intelligence and automation to cut operating costs by nearly $1 billion in 2026. Over 80% of member inquiries now utilize AI tools, which management expects will enhance customer satisfaction and reduce expenses.
\n - Transparency Initiatives: The company has launched independent reviews and public reporting on business practices, risk management, and pharmacy services. Management is committed to sharing key operational metrics, such as prior authorization and claim approval rates, to build trust and transparency.
\n
\n\nWhat Will Drive Future Results?
\nUnitedHealth’s outlook is shaped by a focus on margin recovery, operational efficiency, and adapting to ongoing funding challenges in government programs.
\n\n - Margin Expansion: The company is emphasizing repricing, market rationalization, and cost control, particularly in Medicare Advantage and commercial segments. While these efforts may reduce membership, they are designed to boost operating margins.
\n - Technology and AI: UnitedHealth is investing about $1.5 billion in AI and technology upgrades to enhance productivity and service. These investments are expected to significantly lower operating costs and foster new product innovation, especially within OptumInsight.
\n - Government Funding Risks: Ongoing cuts to Medicare and Medicaid, along with changing regulations, remain key risks. Management anticipates continued enrollment and benefit pressures and is working with CMS to advocate for more sustainable funding.
\n
\n\nUpcoming Catalysts to Watch
\nIn the coming quarters, analysts will be monitoring:
\n\n - The speed and effectiveness of UnitedHealth’s margin recovery in Medicare Advantage and commercial insurance
\n - The real-world impact of AI and technology investments on costs and customer experience
\n - The company’s ability to maintain membership levels amid funding challenges in Medicare and Medicaid
\n - Progress on Optum’s operational reset and evidence of consistent performance improvements
\n
\nUnitedHealth shares are currently trading at $283.55, down from $351.64 before the earnings release. Is this a buying opportunity or a signal to sell?
\n\nTop Stock Picks Right Now
\nThis year’s market rally has been driven by just four stocks, which together account for half of the S&P 500’s total gains. Such concentration can make investors uneasy. While many are crowding into these popular names, savvy investors are seeking out high-quality stocks that are overlooked and undervalued. Explore our curated list of Top 5 Growth Stocks for this month—these companies have delivered a remarkable 244% return over the past five years (as of June 30, 2025).
\nOur selections include well-known leaders like Nvidia, which soared 1,326% from June 2020 to June 2025, as well as lesser-known success stories such as Kadant, which achieved a 351% five-year return. Discover your next potential winner with StockStory today.
","contentId":"12560605171693","contentText":"UnitedHealth (UNH) Q4 2025 Earnings Overview UnitedHealth Group (NYSE:UNH) reported fourth-quarter 2025 revenue that matched Wall Street’s expectations, posting a 12.3% year-over-year increase to $113.2 billion. However, the company’s projected full-year revenue of $439 billion fell 3.7% short of what analysts had anticipated. Adjusted earnings per share for the quarter came in at $2.11, aligning with consensus forecasts. Should You Consider Buying UNH? Curious if UnitedHealth is a smart investment right now? Key Q4 2025 Metrics for UnitedHealth Total Revenue: $113.2 billion (12.3% annual growth), just below the $113.6 billion analyst estimate Adjusted EPS: $2.11, matching analyst expectations Adjusted EBITDA: $4.25 billion, missing projections by 3.7% with a 3.8% margin 2026 Adjusted EPS Guidance: $17.75 at the midpoint, in line with forecasts Operating Margin: 0.3%, a sharp decline from 7.7% a year ago Customer Count: 53.69 million, down from 54.08 million in the previous quarter Market Cap: $256.1 billion Analysis and Outlook The fourth quarter presented notable hurdles for UnitedHealth, with leadership highlighting increased medical costs and fierce competition in Medicare Advantage as major factors. CEO Stephen Hemsley described this period as one of intense evaluation, stressing the importance of focusing on the company’s core strengths and realigning operations. The leadership team has initiated restructuring, asset sales, and a renewed commitment to operational discipline to lay the groundwork for future growth. Tim Noel, CEO of UnitedHealthcare, pointed out that aggressive plan shopping and ongoing funding reductions resulted in higher-than-expected losses in Medicare Advantage membership, while margin improvement efforts required tough choices on pricing and product offerings. Looking ahead, UnitedHealth’s guidance reflects continued challenges from Medicare and Medicaid funding cuts and persistent high medical costs. The company’s strategy is centered on restoring margins, investing in operational improvements, and harnessing artificial intelligence to boost efficiency. Hemsley noted that meaningful progress in UnitedHealthcare is expected in 2026, while Optum’s margin growth will require further operational changes. Plans include repricing insurance products, optimizing market participation, and advancing technology initiatives. Patrick Conway, CEO of Optum, emphasized that a renewed focus on integrated, value-based care and network optimization should gradually improve performance, especially in the latter half of the year. Management Insights Leadership attributed the quarter’s results to higher utilization in Medicare Advantage, competitive enrollment pressures, and restructuring across business units. Priorities included strategic repricing and streamlining operations to support margin recovery and future stability. Medicare Advantage Membership Decline: UnitedHealthcare saw greater-than-expected losses in Medicare Advantage enrollment due to ongoing funding cuts and stiff competition. Management prioritized margin improvement over membership growth, aiming for a 50 basis point margin increase in this segment. Medicaid and Commercial Challenges: State-level Medicaid funding shortfalls continue to pressure the business, leading to expected membership declines. In commercial lines, repricing in response to rising medical costs also led to planned reductions in membership, but these actions are intended to stabilize margins by 2026. Optum Restructuring: Optum underwent significant changes to better align with its value-based care strategy, including narrowing its provider network by nearly 20% and simplifying risk contracts to improve consistency and restore margin targets. AI and Automation: UnitedHealth is leveraging artificial intelligence and automation to cut operating costs by nearly $1 billion in 2026. Over 80% of member inquiries now utilize AI tools, which management expects will enhance customer satisfaction and reduce expenses. Transparency Initiatives: The company has launched independent reviews and public reporting on business practices, risk management, and pharmacy services. Management is committed to sharing key operational metrics, such as prior authorization and claim approval rates, to build trust and transparency. What Will Drive Future Results? UnitedHealth’s outlook is shaped by a focus on margin recovery, operational efficiency, and adapting to ongoing funding challenges in government programs. Margin Expansion: The company is emphasizing repricing, market rationalization, and cost control, particularly in Medicare Advantage and commercial segments. While these efforts may reduce membership, they are designed to boost operating margins. Technology and AI: UnitedHealth is investing about $1.5 billion in AI and technology upgrades to enhance productivity and service. These investments are expected to significantly lower operating costs and foster new product innovation, especially within OptumInsight. Government Funding Risks: Ongoing cuts to Medicare and Medicaid, along with changing regulations, remain key risks. Management anticipates continued enrollment and benefit pressures and is working with CMS to advocate for more sustainable funding. Upcoming Catalysts to Watch In the coming quarters, analysts will be monitoring: The speed and effectiveness of UnitedHealth’s margin recovery in Medicare Advantage and commercial insurance The real-world impact of AI and technology investments on costs and customer experience The company’s ability to maintain membership levels amid funding challenges in Medicare and Medicaid Progress on Optum’s operational reset and evidence of consistent performance improvements UnitedHealth shares are currently trading at $283.55, down from $351.64 before the earnings release. Is this a buying opportunity or a signal to sell? Top Stock Picks Right Now This year’s market rally has been driven by just four stocks, which together account for half of the S&P 500’s total gains. Such concentration can make investors uneasy. While many are crowding into these popular names, savvy investors are seeking out high-quality stocks that are overlooked and undervalued. Explore our curated list of Top 5 Growth Stocks for this month—these companies have delivered a remarkable 244% return over the past five years (as of June 30, 2025). Our selections include well-known leaders like Nvidia, which soared 1,326% from June 2020 to June 2025, as well as lesser-known success stories such as Kadant, which achieved a 351% five-year return. Discover your next potential winner with StockStory today.","createTime":"1769592840412","detailId":"4369909","id":"4369909","imgUrlsList":[],"imgUrlsStr":"","labelTypeList":[],"labelVos":[],"labels":"","languageId":"0","likeCount":0,"myLike":0,"originAuthor":"","originPublishTime":"1769592793000","originUrl":"https://finance.yahoo.com/news/unh-q4-deep-dive-margin-053320572.html","pageType":6,"pathSuffix":"","profileImg":"","readCount":9,"relatedCoinList":[],"relatedCoins":"UNH","retweetsCount":"0","retweetsCountV2":0,"sectionId":"12508313407178","sectionName":"Markets","sectionPathSuffix":"markets","showTime":"1769592793000","siteImg":"https://img.bgstatic.com/multiLang/web/cfe162fef73d2e018d93ed311c178bb6.jpeg","sourceName":"101 finance","title":"UNH Q4 Analysis: Profit Squeeze, Shrinking Membership, and Medicare Challenges Influence Future Prospects","videoUrlsList":[],"videoUrlsStr":"","vip":0},{"abstractContent":"","aiAnalyseLabelInfo":[],"author":"","avatar":"","content":" \n
\n - Cardano focuses on security, scalability upgrades, and long-term infrastructure with reliable staking rewards.
\n - TRON powers massive stablecoin transfers with low fees and offers consistent passive staking income.
\n - Hyperliquid delivers fast decentralized perpetual trading with strong liquidity and growing trader adoption.
\n
\n
February 2026 offers a smart moment to reassess altcoin exposure. Price action now favors networks with real users and proven demand. Speculation alone no longer drives lasting gains. Investors increasingly favor chains that support payments, trading, and decentralized finance. ADA, TRX, and HYPE fit that shift well. Each of these promising tokens serves a different role across crypto infrastructure. Together, these assets balance stability, income, and growth potential without chasing risky hype.
\n
Cardano (ADA)
\n
\n
![](\"https://img.bgstatic.com/spider-data/8559f4acec662542023057faf1a6a2861769592625202.png\")
Source: Trading View \n
\n
Cardano follows a careful and research-driven path. That approach attracts builders who value security and long-term planning. ADA trades near $0.4249 with a market value close to $15 billion. The network runs on the Ouroboros proof-of-stake model, which prioritizes efficiency and safety. Recent upgrades strengthened smart contract flexibility through Plutus improvements. Hydra also arrived as a layer two scaling solution. That upgrade improves transaction speed without hurting decentralization. Cardano also supports government and enterprise pilots across Africa and Latin America. These projects include digital identity and payment systems.ADA does not chase fast gains. The focus stays on reliability and durability. Staking rewards and low energy usage add appeal. ADA fits investors who want steady exposure instead of explosive risk.
\n
TRON (TRX)
\n
\n
![](\"https://img.bgstatic.com/spider-data/c0fa3f8013d755c893bc9fab42fb73361769592625279.png\")
Source: Trading View \n
\n
TRON Blockchain processes massive stablecoin activity every day. Many traders overlook that strength. TRX trades near $0.30 with a market cap above $28 billion. The network supports fast and cheap transfers, especially for USDT. Emerging markets rely on TRON for daily payments and remittances. Southeast Asia drives much of that demand. DeFi platforms and gaming apps also operate across the network. Usage remains strong despite ongoing criticism around centralization. Justin Sun’s involvement sparks debate. Still, real usage continues to grow. TRX also offers staking yields between five and seven percent. That income stream appeals during uncertain market cycles. TRON works well for investors seeking utility and passive rewards.
\n
Hyperliquid (HYPE)
\n
\n
![](\"https://img.bgstatic.com/spider-data/49816a0ed125e1a3626e59233bd7c8301769592625353.png\")
Source: Trading View \n
\n
Hyperliquid targets serious traders. The platform powers decentralized perpetual trading with near-instant execution. HYPE trades around $25.68 with a market value above $7.75 billion. The exchange offers order books, zero gas fees, and fast settlement. Traders enjoy a familiar experience without centralized control. Governance remains active and community-driven. A well-received airdrop helped attract early liquidity. Volume continues to climb as more traders migrate on-chain. Competition remains fierce across derivatives platforms. Security and uptime matter greatly in this space. Still, Hyperliquid shows strong momentum. HYPE suits investors who believe trading infrastructure drives future DeFi growth.
\n
ADA, TRX, and HYPE each serve a clear purpose. Cardano focuses on secure and sustainable development. TRON delivers real payment volume and steady yields. Hyperliquid powers fast and decentralized trading. Together, these altcoins create balance across risk, income, and growth.
\n
\n
\n
